|
Conflict of Interest
Citations 81-90 of 151 total displayed.
|
Past content
(since Apr 1998):
|
- Editorials
Rainbow to Dark Clouds
- Catherine D. DeAngelis
JAMA 2005; 294: 1107.
[Extract]
[Full text]
[PDF]
- Editorials
Reporting Conflicts of Interest, Financial Aspects of Research, and Role of Sponsors in Funded Studies
- Phil B. Fontanarosa; Annette Flanagin; Catherine D. DeAngelis
JAMA 2005; 294: 110-111.
[Extract]
[Full text]
[PDF]
- Books, Journals, New Media
The Truth About the Drug Companies: How They Deceive Us, and What to Do About It; On the Take: How Medicine’s Complicity With Big Business Can Endanger Your Health
- Michael S. Wilkes; Jerome R. Hoffman
JAMA 2005; 293: 3107-3108.
[Extract]
[Full text]
[PDF]
- Commentaries
Physicians and the Investment Industry
- Eric J. Topol; David Blumenthal
JAMA 2005; 293: 2654-2657.
[Extract]
[Full text]
[PDF]
- Editorials
Direct-to-Consumer Advertising: A Haphazard Approach to Health Promotion
- Matthew F. Hollon
JAMA 2005; 293: 2030-2033.
[Extract]
[Full text]
[PDF]
- Medical News & Perspectives
Pharmaceutical Industry Funding for Residencies Sparks Controversy
- Bridget M. Kuehn
JAMA 2005; 293: 1572-1580.
[Extract]
[Full text]
[PDF]
- Perspectives on Care at the Close of Life
Dealing With Conflict in Caring for the Seriously Ill: "It Was Just Out of the Question"
- Anthony L. Back; Robert M. Arnold
JAMA 2005; 293: 1374-1381.
[Abstract]
[Full text]
[PDF]
- Books, Journals, New Media
Overdosed America: The Broken Promise of American Medicine
- Allan S. Detsky
JAMA 2005; 293: 1271.
[Extract]
[Full text]
[PDF]
- Reviews
Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis
- Bruce M. Psaty; Curt D. Furberg; Wayne A. Ray; Noel S. Weiss
JAMA 2004; 292: 2622-2631.
[Abstract]
[Full text]
[PDF]
- Commentaries
Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: A Counterpoint
- Brian L. Strom
JAMA 2004; 292: 2643-2646.
[Extract]
[Full text]
[PDF]
|
|
